Koppikar Utpal
CIK 0001742696
Chief Financial OfficerDirector
Filings
11
Latest Jun 20, 2025
Issuers covered
2
Showing
11 of 11
Page 1
Track record
9 of 9 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 9 | 78% | +7.3% | +9.7% | +42.9% | -44.6% |
| 90 days | 9 | 89% | +28.5% | +45.6% | +62.4% | -44.2% |
| 180 days | 9 | 89% | +34.3% | +57.8% | +76.1% | -40.7% |
| 365 days | 9 | 89% | +59.6% | +63.1% | +81.8% | -5.4% |
Issuers
Companies where Koppikar Utpal has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | 6 | Mar 6, 2023 |
| CCCC | C4 Therapeutics, Inc. | 5 | Jun 20, 2025 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|